PubMed Health⌕ Search

PubMed · 16839058

A systematically generated, pressure-dependent mechanism for high-conversion ethane pyrolysis. 2. Radical disproportionations, missing reaction families, and the consequences of pressure dependence.

Abstract

A previous, companion paper of this work (preceding paper in this issue) systematically developed a pressure-dependent reaction mechanism for the high-conversion pyrolysis of ethane, as studied experimentally by Glasier and Pacey. By combining conventional equilibrium, sensitivity, and reaction pathway analyses, that study identified a complex set of reaction pathways governing the formation and destruction of the important minor products acetylene, propylene, 1,3-butadiene, and benzene, which are pyrocarbon deposition precursors. To more confidently understand, and potentially manipulate, the complex chemistry governing deposition precursors, this work examines in more detail (1) the role of large sets of radical disproportionation reactions in forming the minor products, (2) the consequence of ignoring certain reactions during mechanism construction, (3) the appropriateness of the plug flow assumption used to model the reactor, and (4) the importance of reaction pressure dependence to the predictions of the minor product concentrations. We find that the predicted benzene concentration is sensitive to the presence of a specific, large collection of radical disproportionation reactions, typically neglected in most modeling efforts and of consequence only in the aggregate. Reaction families allowing Diels-Alder reaction, ene reaction, and triplet ethylene formation are safely ignored during model construction for the experimental conditions, but two specific reactions proposed in the literature, which rapidly convert fulvene to benzene, potentially explain the underprediction of benzene by the generated model. However, the rates proposed for these reactions are either unrealistically fast, or unconfirmed. We find the plug flow assumption reasonable in most respects, but its neglect of H-atom diffusion could explain the mechanism's systematic underprediction of hydrogen concentration at longer residence times. Finally, we demonstrate that accurate predictions of the minor product predictions appear to require the systematic treatment of pressure dependence employed by our mechanism generation algorithm. Changing the pressure in the experimental reactor alters the distribution of the minor products, or deposition precursors, through changes in the pressure-dependent reaction rates involved in their formation. We close with suggestions for the future development of automated mechanism generation tools, based on the current results.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

David M Matheu, Jeffrey M Grenda. 2005-06-23. A systematically generated, pressure-dependent mechanism for high-conversion ethane pyrolysis. 2. Radical disproportionations, missing reaction families, and the consequences of pressure dependence.. https://doi.org/10.1021/jp0451647

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Effectiveness of high-dose versus standard-dose influenza vaccines against hospitalisation according to frailty risk: a prespecified analysis of the randomised trial DANFLU-2.

BACKGROUND: Frailty is a major risk factor for influenza-related complications and can influence vaccine effectiveness. We aimed to assess the relative vaccine effectiveness (rVE) of high-dose (HD-IIV) versus standard-dose inactivated influenza vaccine (SD-IIV) in older adults aged 65 years or older according to frailty risk. METHODS: This study was a prespecified analysis of DANFLU-2, an open-label, individually randomised trial, conducted in Denmark during three consecutive influenza seasons (2022-23, 2023-24, and 2024-25). Adults aged 65 years or older were randomised (1:1) to the HD-IIV or SD-IIV group. The primary endpoint was hospitalisation for influenza or pneumonia. Frailty was defined according to the validated Hospital Frailty Risk Score (HFRS) based on ICD-10 codes within 10 years before randomisation. Participants were stratified into three HFRS categories, namely low (<5 points), intermediate (5-15 points), and high (>15 points) frailty risk. The rVE of HD-IIV versus SD-IIV against the primary endpoint was assessed across prespecified HFRS categories and treating HFRS as a continuous variable. Pearson's chi-square test was used to compare safety events across frailty risk groups and randomisation groups. FINDINGS: Among 332&#x2009;438 randomised participants (mean age 73&#xb7;7 years [SD 5&#xb7;8]; 161&#x2009;538 [48&#xb7;6%] were female), 276&#x2009;173 (83&#xb7;1%) had low frailty risk, 52&#x2009;395 (15&#xb7;8%) had intermediate frailty risk, and 3861 (1&#xb7;2%) had high frailty risk. The primary endpoint of hospitalisation for influenza or pneumonia occurred in 1424 (0&#xb7;5%) of 276&#x2009;173 participants with low frailty risk, 761 (1&#xb7;5%) of 52&#x2009;395 with intermediate frailty risk, and 163 (4&#xb7;2%) of 3861 with high frailty risk (relative risk [RR] for intermediate vs low frailty risk 2&#xb7;8 [95% CI 2&#xb7;6-3&#xb7;1]; RR for high vs low frailty risk 8&#xb7;2 [7&#xb7;0-9&#xb7;6]). HFRS as a continuous variable significantly modified the effect of HD-IIV versus SD-IIV against the primary endpoint with higher rVE estimates with increasing HFRS (pinteraction=0&#xb7;020). The rVE was 0&#xb7;2% (95% CI -10&#xb7;8 to 10&#xb7;2) among those with low frailty risk, 13&#xb7;1% (-0&#xb7;4 to 24&#xb7;8) among those with intermediate frailty risk, and 19&#xb7;9% (-10&#xb7;3 to 42&#xb7;1) among those with high frailty risk. No significant interaction was observed when HFRS was assessed according to the prespecified categorical frailty groups (pinteraction=0&#xb7;17). The proportion of participants with at least one serious adverse event increased across frailty risk groups (13&#x2009;366 [4&#xb7;8%] of 275&#x2009;795 for low frailty risk, 5475 [10&#xb7;5%] of 52&#x2009;315 for intermediate frailty risk, and 777 [20&#xb7;2%] of 3850 for high frailty risk; p<0&#xb7;0001), with similar proportions of serious adverse events in the HD-IIV and SD-IIV groups for each frailty risk group. INTERPRETATION: Among adults aged 65 years or older in Denmark, frailty risk might modify the effects of HD-IIV versus SD-IIV against hospitalisation for influenza or pneumonia, with higher rVE estimates with increasing frailty risk. These findings might support considering high-dose influenza vaccines for frail older adults. However, effect modification was not evident when frailty was assessed using prespecified categorical subgroups, and subgroup-specific estimates were imprecise, with 95% CIs crossing the null. These results should be considered exploratory, warranting further investigation. FUNDING: The DANFLU-2 trial was funded by Sanofi.

Journal Article↗